Padua Prediction Score For Vte Risk Calculator

What Is the Padua Prediction Score?

The Padua Prediction Score is a validated clinical risk stratification tool developed to identify hospitalized medical patients at elevated risk for venous thromboembolism (VTE), a condition encompassing deep vein thrombosis (DVT) and pulmonary embolism (PE). Originally published by Barbar et al. in the Journal of Thrombosis and Haemostasis in 2010, the model was derived through multivariate analysis of 1,180 medical inpatients across a prospective cohort study. According to PMC research on VTE risk factors in hospitalized patients, high-risk patients who do not receive prophylaxis face a VTE incidence of approximately 11%, compared to just 0.3% in low-risk patients — a more than 35-fold difference that underscores the clinical importance of accurate risk classification.

The Padua Score Formula

The total Padua Prediction Score is calculated by summing the point values assigned to each applicable risk factor:

• Active Cancer (local or distant metastases, or chemotherapy or radiotherapy within the past 6 months): 3 points
• Previous VTE (excluding superficial vein thrombosis): 3 points
• Reduced Mobility (anticipated bedrest with bathroom privileges for 3 or more days): 3 points
• Known Thrombophilic Condition (antithrombin deficiency, protein C or S deficiency, Factor V Leiden mutation, G20210A prothrombin mutation, or antiphospholipid syndrome): 3 points
• Recent Trauma or Surgery (within the past month): 2 points
• Age 70 Years or Older: 1 point
• Heart and/or Respiratory Failure: 1 point
• Acute Myocardial Infarction or Ischemic Stroke: 1 point
• Acute Infection or Rheumatologic Disorder: 1 point
• Obesity (BMI 30 or Greater): 1 point
• Ongoing Hormonal Treatment (oral contraceptives or hormone replacement therapy): 1 point

The maximum achievable score is 20 points. The validated clinical threshold is a score of 4 or above, which designates high VTE risk and typically prompts evaluation for pharmacological thromboprophylaxis.

Score Interpretation

The Padua score uses a single evidence-based cutoff:

• Score 0 to 3 (Low Risk): In-hospital VTE incidence of approximately 0.3% without prophylaxis. Routine pharmacological anticoagulation is generally not indicated. Early ambulation should be encouraged.
• Score 4 or Higher (High Risk): In-hospital VTE incidence of approximately 11% without prophylaxis. Current guidelines recommend initiating low-molecular-weight heparin (LMWH) or equivalent prophylaxis in the absence of contraindications.

Rationale for Variable Weighting

As documented by Barbar et al. in the original Padua Prediction Score derivation study, the four highest-weighted variables (3 points each) represent the strongest independent predictors of in-hospital VTE. Active cancer promotes hypercoagulability through tumor-associated procoagulants, cytokine release, and direct vessel compression. Prior VTE history signals a persistent or inherited predisposition to thrombosis. Reduced mobility impairs venous return in the deep veins of the lower extremities, creating stasis — a key element of Virchow's Triad. Thrombophilic conditions reflect heritable or acquired defects in the anticoagulation cascade. Recent trauma or surgery earns 2 points, reflecting substantial but transient coagulation pathway activation. The six single-point variables each represent moderate, independently validated elevations in VTE risk.

Worked Clinical Examples

Example 1 — High Risk: A 74-year-old patient admitted for acute community-acquired pneumonia, BMI of 32, expected bedrest for 4 days, with no prior VTE or cancer history. Score: elderly age (1) + acute infection (1) + reduced mobility (3) + obesity (1) = 6 points. This exceeds the threshold of 4; prophylaxis evaluation is indicated.

Example 2 — Low Risk: A 52-year-old patient admitted for observation following a syncopal episode, BMI of 24, fully ambulatory, no comorbidities, no hormonal therapy. Score: 0 points. Low risk; no pharmacological prophylaxis required.

Validation, Accuracy, and Limitations

The Padua Prediction Score was prospectively validated in the original 1,180-patient cohort with a C-statistic (area under the ROC curve) above 0.70, indicating good discriminatory ability. Subsequent external validation studies have confirmed its performance in diverse medical inpatient settings. However, the score was developed for general medical wards and may not generalize to surgical patients (where the Caprini Score is preferred), obstetric patients, or intensive care populations. Importantly, the Padua score assesses VTE risk only — clinicians must separately evaluate bleeding risk before initiating anticoagulation, since thromboprophylaxis confers a bleeding risk of its own. Reassessment during prolonged hospitalization is advisable as clinical status changes.